Evidence map›Paper›PMID 25446355›Full record

ArticleNeuroscience2015

Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice.

Y Zhang, A J Brownstein, M Buonora, K Niikura, A Ho, J Correa da Rosa, M J Kreek, J Ott

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Epigenetic Mechanisms of Opioid Addiction.Biological psychiatry · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Y ZhangThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA. Electronic address: zhangyo@rockefeller.edu.
A J BrownsteinThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
M BuonoraThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
K NiikuraThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
A HoThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
J Correa da RosaLaboratory of Investigative Dermatology, The Rockefeller University, New York, NY 10065, USA.
M J KreekThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA.
J OttInstitute of Psychology, Chinese Academy of Sciences, Beijing, China; The Laboratory of Statistical Genetics, The Rockefeller University, New York, NY, USA.
Rockefeller University · US

Funding

Adolescent Oxycodone Self Administration and Vulnerability to Opiate AbuseR01DA029147 · NIDA · ROCKEFELLER UNIVERSITY · PI ZHANG, YONG · 2011 to 2014
$1.4M
Addictive Drugs-Pharmacology &PhysiologyK05DA000049 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1985 to 2007
$1.0M
NIDA NIH HHS K05 DA000049NIDA NIH HHS NIH1R01DA029147NIDA NIH HHS R01 DA029147
6 · The paper itself

Abstract

Abuse and addiction to prescription opioids such as oxycodone (a short-acting Mu opioid receptor (MOP-r) agonist) in adolescence is a pressing public health issue. We have previously shown differences in oxycodone self-administration behaviors between adolescent and adult C57BL/6J mice and expression of striatal neurotransmitter receptor genes, in areas involved in reward. In this study, we aimed to determine whether oxycodone self-administration differentially affects genes regulating synaptic plasticity in the hippocampus of adolescent compared to adult mice, since the hippocampus may be involved in learning aspects associated with chronic drug self administration. Hippocampus was isolated for mRNA analysis from mice that had self administered oxycodone (0.25 mg/kg/infusion) 2h/day for 14 consecutive days or from yoked saline controls. Gene expression was analyzed with real-time polymerase chain reaction (PCR) using a commercially available "synaptic plasticity" PCR array containing 84 genes. We found that adolescent and adult control mice significantly differed in the expression of several genes in the absence of oxycodone exposure, including those coding for mitogen-activated protein kinase, calcium/calmodulin-dependent protein kinase II gamma subunit, glutamate receptor, ionotropic AMPA2 and metabotropic 5. Chronic oxycodone self administration increased proviral integration site 1 (Pim1) and thymoma viral proto-oncogene 1 mRNA levels compared to controls in both age groups. Both Pim1 and cadherin 2 mRNAs showed a significant combined effect of Drug Condition and Age × Drug Condition. Furthermore, the mRNA levels of both cadherin 2 and cAMP response element modulators showed an experiment-wise significant difference between oxycodone and saline control in adult but not in adolescent mice. Overall, this study demonstrates for the first time that chronic oxycodone self-administration differentially alters synaptic plasticity gene expression in the hippocampus of adolescent and adult mice.

Indexed as

AgingAnimalsCadherinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cyclic AMP Response Element ModulatorGene ExpressionGene Expression Regulation, DevelopmentalHippocampusMaleMice, Inbred C57BLMitogen-Activated Protein Kinase 1NarcoticsOpioid-Related DisordersOxycodoneProto-Oncogene Proteins c-pim-1Receptor, Metabotropic Glutamate 5CadherinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Camk2g protein, mouseCdh2 protein, mouseCrem protein, mouseCyclic AMP Response Element Modulatorglutamate receptor ionotropic, AMPA 2Grm5 protein, mouseMapk1 protein, mouseMitogen-Activated Protein Kinase 1NarcoticsOxycodonePim1 protein, mouseProto-Oncogene Proteins c-pim-1Receptor, Metabotropic Glutamate 5Receptors, AMPARNA, Messengeradolescentadultgene expressionhippocampusoxycodone self-administrationsynaptic plasticity

Identifiers

PMID25446355
PMCPMC5848094
OpenAlexW1970468642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.